Weimei Health
Series A in 2025
Weimei Health is a provider of smart solutions for medical information technology
Xi'an Dunbo Medical Equipment
Series A in 2025
Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices. The products currently under development are cardiac pacemakers and brain pacemakers, Cardiac defibrillators. Self-developed products include chips, hardware circuits, software application systems, and structural materials.
Windward Bio
Series A in 2025
Windward Bio is a clinical-stage biopharmaceutical company dedicated to enhancing outcomes for patients with advanced immunological diseases, focusing on severe respiratory conditions. The company is advancing a fully human monoclonal antibody targeting thymic stromal lymphopoietin (TSLP) into phase 2 clinical trials. This antibody, administered subcutaneously, potently binds to the TSLP ligand, extending its half-life and silencing its effector functions. Windward Bio is also developing innovative bispecific programs for other immunological disorders, led by a team of experienced biopharmaceutical executives aiming to address significant unmet medical needs in this field.
Matwings Technology
Series A in 2024
Matwings Technology is a biotechnology company specializing in the design of functionally optimized proteins through advanced evolutionary methods. Utilizing proprietary techniques, the company focuses on computational chemistry and artificial intelligence-driven drug molecular design. Matwings collaborates with major pharmaceutical firms to facilitate early-stage research and development of innovative drugs targeting complex and clinically valuable challenges. By leveraging its expertise, Matwings aims to achieve significant breakthroughs in drug formulation, enhancing the potential for new therapeutic solutions.
Tianhu Technology
Series A in 2024
Tianhu Technology provides drug research and development services through independent collaborative closed-loop iterations, deeply integrating AI solutions with the drug development and production process. Tianhu Technology is an innovative drug R&D company that offers high-throughput phenotypic screening and physical computing technology, as well as AI solutions that are deeply integrated into the drug R&D process.
Bioyond Tech
Series A in 2024
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Bytelumio
Series A in 2024
Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
Epigenic Therapeutics
Series A in 2024
Epigenic Therapeutics is a biotechnology company focused on developing gene editing therapies that leverage gene-silencing technology to address a range of diseases. The firm specializes in epigenome editing, aiming to regulate various conditions, including those related to ophthalmology, neurodegeneration, metabolism, and rare diseases. By creating innovative treatments, Epigenic Therapeutics seeks to offer effective solutions for patients suffering from chronic and severe health issues.
Candid Therapeutics
Series A in 2024
Candid Therapeutics is a biotechnology company specializing in the development of innovative therapies for immunological disorders. The company's primary focus is on creating novel, user-friendly treatments for autoimmune diseases. Their core technology involves advanced T-cell engager antibodies, which precisely redirect T-cells to selectively eliminate autoreactive B-cells, aiming to deliver transformative efficacy and improved therapeutic outcomes for patients.
Infinigence
Series A in 2024
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
Guangjing Energy
Series A in 2024
Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.
Dr.Clear Aligner
Series A in 2024
Dr.Clear is an oral invisible orthodontic solution service provider that specializes in offering safe and comfortable digital solutions for face development management and invisible dental correction for children and adolescents.
CSR Biotech
Series A in 2024
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.
LTZ Therapeutics
Series A in 2024
LTZ Therapeutics specializes in the development of innovative immunotherapies aimed at treating patients with cancer and other diseases that currently lack effective treatment options. By employing reverse translational science and tumor biology in conjunction with machine learning, the company focuses on creating novel cancer therapies. This approach enables the identification and development of targeted treatments that address unmet clinical needs, ultimately improving patient outcomes in the field of oncology and beyond.
Thorough Future
Series A in 2024
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.
Horizone Technologies
Series A in 2024
Horizone Technologies is membrane materials and excellent filtration solutions manufacturer focusing on the R&D and production
Pinnacle Medicines
Series A in 2024
Pinnacle Medicines is a peptide drug discovery company located in Doylestown, Pennsylvania. The company specializes in developing peptide modalities to address various medical needs. Utilizing AI-based drug design tools, Pinnacle Medicines conducts research aimed at creating safe, effective, and convenient therapeutics for unmet medical conditions. Through its innovative approach, the company seeks to enhance the efficacy of peptide drugs in the pharmaceutical landscape.
Silicon Yi Technology
Venture Round in 2024
Silicon Yi Technology is a biotech firm specializing in RNA nanopesticide research and development designed to target pests and diseases.
Magair Chemical
Series A in 2024
Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, and significantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.
Swap is a company that makes a battery interchange system that is designed to replace the traditional charging process for electric motors. The company offers an energy switching system comprised of both energy stations and handmade batteries that can be used with the assistance of a mobile application, allowing users to supply speed and timeliness to bike riders at a low cost. The company aims to support the nation's zero-emission goal by providing the revolutionized charging infrastructure
ACXEL Tech specializes in developing advanced large-area electronics that enable innovative applications in drug discovery and biological research. The company's proprietary digital microfluidic platform utilizes millions of 'active' pixels to manipulate liquid droplets with high precision and speed. This technology serves as a programmable and cost-effective solution for various applications, including fundamental bio-related research, cell line development, cell therapy, synthetic biology, and antibody therapy. By allowing clients to conduct complex experimental procedures at the single-cell level, ACXEL enhances productivity and efficiency within the fields of chemistry, biology, and medtech.
Sano Dynamics
Series A in 2023
Sano Dynamics is a producer of hydraulic system core components and hydraulic industrial robots.
Infinigence
Series A in 2023
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
Sanegene Bio
Series A in 2023
Sanegene Bio is a biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. Its innovative RNAi drug discovery platform targets disease-causing genes, effectively knocking them down to provide potential treatments for conditions such as cardiovascular and metabolic diseases, immunology-related disorders, and diseases affecting the nervous system. By leveraging advanced RNA technology, Sanegene Bio is capable of achieving specific delivery of multiple RNA drugs, enhancing the effectiveness of its therapeutic offerings for patients suffering from a range of health issues, including infectious diseases and eye conditions.
Tachem is a biotechnology company that develops, produces, and distributes a range of products derived from the protected amino acid series. These products cater to diverse industries, including medical, healthcare, food, and cosmetics, among others. Tachem's primary offerings comprise protective amino acids, non-natural amino acids, and high-quality chemical raw materials, serving as biotechnical solutions for various industrial users.
Shennapsi Artificial Intelligence Technology
Series A in 2023
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Lixin Huigan
Series A in 2023
Lixin Huigan is a full-service manufacturer of sensors and an application service provider with an emphasis on the creation of premium micro-nanosensors.
Casela is a chip and semiconductor company
Congnitact
Series A in 2023
risk prediction, diagnostic, and disease monitoring tool for dementia, aiming to detect Alzheimer's disease
iNexBot is a developer and manufacturer specializing in robot motion controllers and industrial robot intelligence technology. The company focuses on the research and development of advanced solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot provides essential hardware and software components, including control systems, robot cabinets, and fieldbus IO, to support robot manufacturers in enhancing their robotic products. Additionally, the company is involved in developing machine vision technology and laser seam tracking technology, further expanding its offerings in the robotics field.
CSR Biotech
Series A in 2023
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.
Epigenic Therapeutics
Series A in 2023
Epigenic Therapeutics is a biotechnology company focused on developing gene editing therapies that leverage gene-silencing technology to address a range of diseases. The firm specializes in epigenome editing, aiming to regulate various conditions, including those related to ophthalmology, neurodegeneration, metabolism, and rare diseases. By creating innovative treatments, Epigenic Therapeutics seeks to offer effective solutions for patients suffering from chronic and severe health issues.
P0x labs is the team behind Manta Network is a privacy-preserving technology operating on the Polkadot blockchain.
AskGene Pharma
Series A in 2023
AskGene Pharma is a biotechnology firm focused on developing innovative therapies for oncology and autoimmune diseases through its novel cytokine prodrug platform. This technology aims to unlock the full therapeutic potential of cytokine molecules, addressing significant challenges associated with current cytokine therapeutics. By avoiding systemic pharmacokinetic sinks and modulating specific immune cells within the tumor microenvironment, AskGene Pharma strives to deliver safer and more effective treatments. The company is dedicated to providing next-generation therapies to patients with critical unmet medical needs, leveraging advanced research and development facilities to advance its mission of improving patient outcomes.
Manta Network
Series A in 2023
Manta Network is focused on creating a secure and interoperable digital ecosystem through the use of Zero-Knowledge technology. The company operates a decentralized exchange platform designed to protect user privacy and prevent tracking of activities. By utilizing a protocol based on substrate frameworks, Manta Network offers end-to-end anonymity, high throughput, and robust cross-chain interoperability. This enables users to exchange data in a secure environment, prioritizing privacy and security in their transactions.
Tenpoint Therapeutics
Series A in 2023
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Guangjing Energy
Series A in 2023
Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.
Thorough Future
Series A in 2023
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.
CIX Technology
Series A in 2023
CIX Technology is a developer of high-performance, next-generation intelligent computing solutions, specializing in the creation of general-purpose intelligent computing chips and computer CPUs. The company focuses on energy-efficient computing technologies that utilize ARM architecture. Its chips are designed for terminal general intelligent computing applications, including notebooks, desktops, high-end tablets, and augmented and virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to produce advanced electronics and other products, ultimately increasing the speed and efficiency of computing across various scenarios.
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.
Complete Omics
Series A in 2023
Complete Omics is a company focused on the development of multi-omics diagnostics for early disease detection, particularly in cancer. The firm specializes in creating personalized diagnosis and treatment platforms that leverage advanced technologies across various omics fields. With patented innovations, Complete Omics offers precision companion diagnostics that enhance the ability to conduct sensitive and specific health surveillance tests. By enabling researchers and pharmaceutical companies to utilize these sophisticated tools, Complete Omics aims to improve diagnosis and treatment outcomes in the field of oncology.
Zeen Health
Series A in 2023
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.
NFTGO
Convertible Note in 2023
NFTGo is a data aggregation platform focused on the non-fungible token (NFT) market. It provides users with comprehensive information about NFTs, including details on NFT drops, rankings, whale tracking, and market data. The platform employs a proprietary blockchain data collection engine to gather the latest on-chain transaction data, which it then organizes into accessible formats for users. This functionality allows NFT project stakeholders to effectively acquire customers and enables users to stay informed about emerging trends in the NFT market.
Joes Future Food
Series A in 2023
Joes Future Food engages the development, production, testing, and sales of raw and auxiliary materials for food and biological products.
Brise Pharma
Series A in 2023
Brise Pharma is a scientific research company specializing in developing novel biopharmaceutical drugs for treating pain. Its primary focus lies in creating innovative and distinct analgesic treatments targeting migraine, neuropathic, and musculoskeletal pain, aiming to provide safe, effective, and accessible pain relief solutions globally.
Bioyond Tech
Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Qianshou is a dating application that helps to find the right partner for life by using artificial matchmaker service.
Deepway is a manufacturer of smart vehicles focused on providing intelligent driving solutions for the truck freight market. The company specializes in heavy-duty trucks characterized by low wind resistance bodies and advanced intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design, which operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.
Ricoton is a medical device company based in Hunan, China, specializing in the development and production of devices for cerebrovascular diseases. Founded in 2011, the company offers a range of products designed for interventional medicine, including microcatheters, guidewires, and various vascular access devices. Notably, Ricoton's equipment features a comprehensive set that includes a micro guide wire, micro catheter, support catheter, thrombectomy stent, balloon guide catheter, and intracranial balloon dilatation catheter. This innovative lineup provides a one-stop thrombectomy solution aimed at enhancing the treatment and prevention of cerebrovascular conditions.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Xinchuangyuan Semiconductor
Series A in 2023
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Swords & Dungeons
Series A in 2023
Swords & Dungeons is a developer specializing in massively multiplayer online role-playing games (MMORPGs) and Web3 multi-chain game software. The company focuses on creating and providing content that enhances the gaming experience, including user interfaces and regular updates for its games. By leveraging decentralized technologies, Swords & Dungeons aims to deliver engaging and innovative social entertainment, allowing users to explore new types of gaming experiences.
Biotree Technology
Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.
Shennapsi Artificial Intelligence Technology
Series A in 2022
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Veridise is a comprehensive blockchain security company founded by a team of renowned researchers. Specializing in auditing Zero-Knowledge Circuits and MetaMask Snaps, the firm possesses extensive expertise in smart contracts, blockchains, Layer 2 solutions, DeFi protocols, cryptocurrency wallets, tokens, and NFTs. Veridise has established a reputation for uncovering critical vulnerabilities that other auditing firms often overlook, identifying over 100 high-severity bugs in the first half of 2023 alone. The company's approach combines traditional auditing methods with advanced automated Web3 security tools, allowing them to tackle complex blockchain security challenges effectively. Through this innovative hybrid methodology, Veridise provides clients with detailed and actionable audit reports, enhancing the overall security of blockchain applications.
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.
Entact Bio
Series A in 2022
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
Reunion Biotech
Series A in 2022
Reunion Biotech focuses on the research and development and industrial transformation of medical hydrogels. The company is committed to becoming an international leading hydrogel technology platform. The current pipeline includes systemic solutions for tumor radiotherapy protection, wound repair, tumor embolization, and drug delivery.
BayOmics is a high-tech enterprise specializing in the commercial development and application of proteomics research. The company utilizes integrated automated proteomics technology to perform functional proteome analysis and facilitate the discovery of new drug targets. By focusing on targeted drug research and development using micro-clinical samples, BayOmics aims to provide crucial technical support to the medical industry. This support is particularly geared towards the development of treatments for critical illnesses, including cancer and other significant diseases.
Sanegene Bio
Series A in 2022
Sanegene Bio is a biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. Its innovative RNAi drug discovery platform targets disease-causing genes, effectively knocking them down to provide potential treatments for conditions such as cardiovascular and metabolic diseases, immunology-related disorders, and diseases affecting the nervous system. By leveraging advanced RNA technology, Sanegene Bio is capable of achieving specific delivery of multiple RNA drugs, enhancing the effectiveness of its therapeutic offerings for patients suffering from a range of health issues, including infectious diseases and eye conditions.
Sunny Dental
Series A in 2022
Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a comprehensive range of orthodontic services. The company provides diagnosis and treatment for dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp issues, and oral and maxillofacial surgery. Sunny Dental is dedicated to offering professional care and advanced solutions in various aspects of dental health, ensuring a focus on both preventative and restorative treatments.
PureVision
Series A in 2022
PureVision focuses on developing medical devices for ophthalmology. PureVision was founded in 2022 and was headquartered in Wenzhou, Zhejiang China.
PlusLife Biotech
Series A in 2022
PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.
Bitworx is a technology company headquartered in Chengdu, China, specializing in product development and applications that leverage advanced algorithm and chip technology. The company's focus is on enhancing communication, sensing, and detection capabilities. Currently, Bitworx is operating in stealth mode, which indicates a strategic approach to its operations and product offerings, allowing for innovation and development away from public scrutiny. Through its expertise in cutting-edge technology, Bitworx aims to create solutions that meet emerging demands in various sectors.
Thorough Future
Series A in 2022
Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.
Soda Health
Series A in 2022
Soda Health, established in 2021 with its headquarters in Chicago, Illinois, is a healthcare technology company focused on reducing health disparities by addressing social determinants of health. The company operates a platform designed to help individuals identify, access, and afford necessary resources for leading healthier lives. This platform facilitates personalized benefit administration and reimbursement, bridging the gap between medical claims and retail payments more cost-effectively than traditional methods.
Dezhen Technology
Series A in 2022
Dezhen Technology provides solutions for medical institutions to help hospitals develop clinical, and scientific research management. Dezhen Technology is headquartered in Hongkou, China.
XellSmart
Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
KouTech develops surgical robots that can perform ophthalmic surgery, trans-gastroscopic, and general-purpose microsurgery. KouTech was founded in 2022 and was headquartered in Shanghai, China.
Deepway is a manufacturer of smart vehicles focused on providing intelligent driving solutions for the truck freight market. The company specializes in heavy-duty trucks characterized by low wind resistance bodies and advanced intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design, which operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.
OPUS develops clinically applicable tissue engineering products and treatments.
GluBio Therapeutics
Series A in 2022
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
P0xeidon Labs
Series A in 2022
P0xeidon Labs focuses on building web3 privacy, creating, and deploying tools.
Auron Therapeutics
Series A in 2022
Auron Therapeutics, Inc. is a biotechnology company based in Wellesley, Massachusetts, founded in 2018. The company is dedicated to developing innovative therapies for cancer, aiming to shift the traditional focus from merely killing cancer cells to transforming malignant cells into normal, functioning cells through a process known as differentiation therapy. This approach seeks to reactivate the body's innate cellular programs, promoting tumor cell maturation and the restoration of normal tissue. Auron Therapeutics leverages advanced platforms that integrate large genomic datasets and utilize high-throughput flow cytometry to efficiently identify and validate potential drug targets in primary human patient samples. Through its research, the company aims to address significant unmet medical needs in oncology, ultimately striving to deliver life-saving and transformative treatments for cancer patients.
Biotree Technology
Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.
Resunbio provides micro-nano processing research and development precipitation. Resunbio is headquartered in Longhua, China.
Crema Finance
Series A in 2022
Crema Finance is a developer of a protocol focused on concentrated liquidity to enhance decentralized trading. The company provides a range of services, including NFT farming, integrated aggregators, and Web3 infrastructure. It has also created an advanced algorithm that allows liquidity providers to concentrate their liquidity within specific price ranges, thereby optimizing their returns. This algorithm benefits traders by enabling them to execute swaps with reduced price slippage. Additionally, Crema Finance's services are designed to assist developers in integrating these capabilities into decentralized applications (DApps) and strengthening the decentralized finance (DeFi) ecosystem.
AskGene Pharma
Series A in 2022
AskGene Pharma is a biotechnology firm focused on developing innovative therapies for oncology and autoimmune diseases through its novel cytokine prodrug platform. This technology aims to unlock the full therapeutic potential of cytokine molecules, addressing significant challenges associated with current cytokine therapeutics. By avoiding systemic pharmacokinetic sinks and modulating specific immune cells within the tumor microenvironment, AskGene Pharma strives to deliver safer and more effective treatments. The company is dedicated to providing next-generation therapies to patients with critical unmet medical needs, leveraging advanced research and development facilities to advance its mission of improving patient outcomes.
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.
Jiiov Technology
Series A in 2022
Jiiov Technology is a provider of biometric recognition solutions specializing in fingerprint identification products tailored for intelligent terminals. The company develops advanced algorithms for artificial intelligence-driven fingerprint recognition, including innovative extreme finger fingerprint algorithms. In addition to algorithm development, Jiiov Technology focuses on professional sensor design, optical design, module design, and specialized computing. This comprehensive suite of offerings enables effective law and software integration, enhancing the fingerprint capabilities of intelligent terminal devices.
Tingsheng Technology
Series A in 2022
TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digital heart model.
GluBio Therapeutics
Series A in 2022
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
Medmotion
Series A in 2022
Medmotion operates a comprehensive sports rehabilitation clinic in China, specializing in a range of services designed to support athletes and individuals recovering from injuries. The clinic offers musculoskeletal system manipulation, imaging examination evaluations, and perioperative rehabilitation for orthopedic and sports-related issues. Additionally, Medmotion provides conservative treatment and rehabilitation for trauma and sports injuries, along with digital customized orthopedic braces. The clinic also addresses common occupational diseases and offers professional sports protection guidance, ensuring that clients receive efficient and effective rehabilitation services. Medmotion's focus on sports medicine aims to shorten recovery times and enhance overall patient outcomes.
Wowjoy Technology
Series A in 2022
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.
Cencorp Automation
Series A in 2022
Cencorp Automation is a provider of process automation solutions focused on the electronics industry. The company offers a diverse range of equipment solutions, including depaneling, odd-form assembly, test handling, laser marking, laser welding, and final assembly. Cencorp aims to enhance the productivity and quality of its clients' production processes through innovative automation platforms. The company's clientele includes prominent players in sectors such as car electronics, telecommunications, and industrial electronics, highlighting its commitment to delivering effective and affordable automation solutions.
Xiaoniao Kuaiyan
Series A in 2022
Xiaoniao Kuaiyan is a Beijing-based company that specializes in home physical examination services. It offers a range of health-related services, including regular check-ups, tumor screening, infection tests, chronic disease surveillance, and customized health assessments. In addition to its core services, the company facilitates business cooperation between enterprises and provides customer service and professional training. Xiaoniao Kuaiyan also focuses on quality management by formulating procedures for quality inspection and developing a comprehensive product knowledge base.
Ceptur Therapeutics
Series A in 2022
Ceptur Therapeutics is focused on developing innovative genetic medicines for patients with unmet medical needs. The company utilizes its proprietary U1 Adaptor technology to achieve non-genotoxic, long-lasting silencing of disease-causing genes, particularly in challenging tissues beyond the liver and central nervous system. This technology addresses the limitations of existing gene silencing methods and has potential applications in cancer treatment, allowing healthcare providers to offer new therapeutic options for various cancer types. Through its advancements, Ceptur aims to improve patient outcomes by providing effective solutions for difficult-to-treat conditions.
Axera is a high-tech semiconductor company specializing in the development of advanced artificial intelligence (AI) System-on-Chips (SoCs) for computer applications. The company's flagship product is an AI chip designed to excel in visual processing tasks, offering superior performance at low power consumption and latency, while maintaining high integration capabilities. This enables clients to perform real-time video analysis on devices, capture high-quality videos, and integrate multiple cameras efficiently with reduced costs.
MKSEMI is a low-power ultra-wideband (UWB) company, provides a complete high precision location solution for device OEMs and ODMs.
Ruining Bio
Series A in 2022
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
SUPERHEXA
Series A in 2021
Superhexa is a Beijing-based hardware company founded on October 15, 2020, by Xia Yongfeng. The firm specializes in developing innovative personal consumer electronics designed to seamlessly integrate technology into everyday life. By focusing on enhancing user experiences, Superhexa aims to create products that cater to the evolving needs of consumers in a technology-driven world.
Xinchuangyuan Semiconductor
Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Gemsouls is an artificial intelligence company that develops technology to create virtual characters and facilitate their interactions with the real world. The platform aims to offer fans a novel way to engage with their favorite characters, enabling lasting connections with both fictional and real-life figures. By leveraging AI, Gemsouls enhances the experience of users, allowing them to stay connected to those they cherish, whether they are beloved characters from stories or significant individuals in their lives.
Allorion Therapeutics
Series A in 2021
Allorion Therapeutics is a small molecule therapeutic development company specializing in the treatment of cancer and autoimmune diseases. With operations in Natick, Massachusetts, and Guangzhou, China, Allorion focuses on creating mutant selective and isoform-specific drugs through innovative methods targeting established medical challenges. By concentrating on enhancing drug efficacy and preventing resistance in patients, the company aims to improve therapeutic outcomes in these critical areas of healthcare.
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.
Cubenergy Technology
Series A in 2021
Cubenergy Technology is an energy technology company specializing in energy data operation services and the integration of distributed energy storage systems. The company develops advanced energy management and storage systems that utilize data analysis to optimize performance and maintain system efficiency. By providing innovative solutions in energy management, Cubenergy Technology aims to enhance the operation of energy storage systems, ensuring that users achieve optimal control and performance in their energy applications.
Shimmer is an app that provides companionship. Whether chatting, watching videos, playing games, or singing karaoke, it can all help in finding a chat topic.